Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC) | MicrobiomeTrials← Back to trialsNCT06988150
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-04-14Est. Completion: 2026-04-14
Enrollment target: 100 participants Locations- Cedars-Sinai Medical Center, Los Angeles, California, United States
Other microbiome trials you might be interested in
Pancreas CancerOligometastatic
The EXPAND trial (EXtending outcomes for PAncreas cancer patients with Nominal oligometastatic Disease) is a randomized …
Camden, United StatesEst. completion Jun 29, 2029
Advanced/Metastatic Solid Tumors
This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design…
Los Angeles, United StatesEst. completion Jun 2028
Phase 3
Recruiting
Pancreatic CancerPancreatic Cancer MetastaticPDACPDAC - Pancreatic Ductal AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Adenocarcinoma
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compar…
Phoenix, United StatesEst. completion Jun 2028